0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Celecoxib Capsule Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-26K2970
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Celecoxib Capsule Market Report Forecast 2022 2028
BUY CHAPTERS

Global Celecoxib Capsule Market Insights, Forecast to 2030

Code: QYRE-Auto-26K2970
Report
December 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Celecoxib Capsule Market

Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.
Market Analysis and Insights: Global Celecoxib Capsule Market
The global Celecoxib Capsule market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Celecoxib Capsule is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Celecoxib Capsule is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Celecoxib Capsule is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Celecoxib Capsule include Pfizer, Teva, Mylan, Apotex, Lupin and HENGRUI MEDICINE, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Celecoxib Capsule is widely used in various fields, such as Rheumatoid Arthritis, Osteoarthritis, Acute Pain and Musculoskeletal Pain, etc. Rheumatoid Arthritis provides greatest supports to the Celecoxib Capsule industry development. In 2023, global % revenue of Celecoxib Capsule went into Rheumatoid Arthritis filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Celecoxib Capsule market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Celecoxib Capsule, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Celecoxib Capsule, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Celecoxib Capsule revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Celecoxib Capsule market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Celecoxib Capsule revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Celecoxib Capsule Market Report

Report Metric Details
Report Name Celecoxib Capsule Market
Segment by Type
  • 50mg
  • 100mg
  • 200mg
  • 400mg
Segment by Application
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Acute Pain
  • Musculoskeletal Pain
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Teva, Mylan, Apotex, Lupin, HENGRUI MEDICINE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Celecoxib Capsule in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Celecoxib Capsule companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib Capsule revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Celecoxib Capsule Market report?

Ans: The main players in the Celecoxib Capsule Market are Pfizer, Teva, Mylan, Apotex, Lupin, HENGRUI MEDICINE

What are the Application segmentation covered in the Celecoxib Capsule Market report?

Ans: The Applications covered in the Celecoxib Capsule Market report are Rheumatoid Arthritis, Osteoarthritis, Acute Pain, Musculoskeletal Pain, Others

What are the Type segmentation covered in the Celecoxib Capsule Market report?

Ans: The Types covered in the Celecoxib Capsule Market report are 50mg, 100mg, 200mg, 400mg

Recommended Reports

Capsule Drug Markets

Pain Management Drugs

Arthritis and NSAIDs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celecoxib Capsule Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Celecoxib Capsule Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Acute Pain
1.3.5 Musculoskeletal Pain
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celecoxib Capsule Market Perspective (2019-2030)
2.2 Global Celecoxib Capsule Growth Trends by Region
2.2.1 Celecoxib Capsule Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Celecoxib Capsule Historic Market Size by Region (2019-2024)
2.2.3 Celecoxib Capsule Forecasted Market Size by Region (2025-2030)
2.3 Celecoxib Capsule Market Dynamics
2.3.1 Celecoxib Capsule Industry Trends
2.3.2 Celecoxib Capsule Market Drivers
2.3.3 Celecoxib Capsule Market Challenges
2.3.4 Celecoxib Capsule Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Celecoxib Capsule by Players
3.1.1 Global Celecoxib Capsule Revenue by Players (2019-2024)
3.1.2 Global Celecoxib Capsule Revenue Market Share by Players (2019-2024)
3.2 Global Celecoxib Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Celecoxib Capsule, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Celecoxib Capsule Market Concentration Ratio
3.4.1 Global Celecoxib Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celecoxib Capsule Revenue in 2023
3.5 Global Key Players of Celecoxib Capsule Head office and Area Served
3.6 Global Key Players of Celecoxib Capsule, Product and Application
3.7 Global Key Players of Celecoxib Capsule, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Celecoxib Capsule Breakdown Data by Type
4.1 Global Celecoxib Capsule Historic Market Size by Type (2019-2024)
4.2 Global Celecoxib Capsule Forecasted Market Size by Type (2025-2030)
5 Celecoxib Capsule Breakdown Data by Application
5.1 Global Celecoxib Capsule Historic Market Size by Application (2019-2024)
5.2 Global Celecoxib Capsule Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Celecoxib Capsule Market Size (2019-2030)
6.2 North America Celecoxib Capsule Market Size by Type
6.2.1 North America Celecoxib Capsule Market Size by Type (2019-2024)
6.2.2 North America Celecoxib Capsule Market Size by Type (2025-2030)
6.2.3 North America Celecoxib Capsule Market Share by Type (2019-2030)
6.3 North America Celecoxib Capsule Market Size by Application
6.3.1 North America Celecoxib Capsule Market Size by Application (2019-2024)
6.3.2 North America Celecoxib Capsule Market Size by Application (2025-2030)
6.3.3 North America Celecoxib Capsule Market Share by Application (2019-2030)
6.4 North America Celecoxib Capsule Market Size by Country
6.4.1 North America Celecoxib Capsule Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Celecoxib Capsule Market Size by Country (2019-2024)
6.4.3 North America Celecoxib Capsule Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Celecoxib Capsule Market Size (2019-2030)
7.2 Europe Celecoxib Capsule Market Size by Type
7.2.1 Europe Celecoxib Capsule Market Size by Type (2019-2024)
7.2.2 Europe Celecoxib Capsule Market Size by Type (2025-2030)
7.2.3 Europe Celecoxib Capsule Market Share by Type (2019-2030)
7.3 Europe Celecoxib Capsule Market Size by Application
7.3.1 Europe Celecoxib Capsule Market Size by Application (2019-2024)
7.3.2 Europe Celecoxib Capsule Market Size by Application (2025-2030)
7.3.3 Europe Celecoxib Capsule Market Share by Application (2019-2030)
7.4 Europe Celecoxib Capsule Market Size by Country
7.4.1 Europe Celecoxib Capsule Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Celecoxib Capsule Market Size by Country (2019-2024)
7.4.3 Europe Celecoxib Capsule Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Celecoxib Capsule Market Size (2019-2030)
8.2 China Celecoxib Capsule Market Size by Type
8.2.1 China Celecoxib Capsule Market Size by Type (2019-2024)
8.2.2 China Celecoxib Capsule Market Size by Type (2025-2030)
8.2.3 China Celecoxib Capsule Market Share by Type (2019-2030)
8.3 China Celecoxib Capsule Market Size by Application
8.3.1 China Celecoxib Capsule Market Size by Application (2019-2024)
8.3.2 China Celecoxib Capsule Market Size by Application (2025-2030)
8.3.3 China Celecoxib Capsule Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Celecoxib Capsule Market Size (2019-2030)
9.2 Asia Celecoxib Capsule Market Size by Type
9.2.1 Asia Celecoxib Capsule Market Size by Type (2019-2024)
9.2.2 Asia Celecoxib Capsule Market Size by Type (2025-2030)
9.2.3 Asia Celecoxib Capsule Market Share by Type (2019-2030)
9.3 Asia Celecoxib Capsule Market Size by Application
9.3.1 Asia Celecoxib Capsule Market Size by Application (2019-2024)
9.3.2 Asia Celecoxib Capsule Market Size by Application (2025-2030)
9.3.3 Asia Celecoxib Capsule Market Share by Application (2019-2030)
9.4 Asia Celecoxib Capsule Market Size by Region
9.4.1 Asia Celecoxib Capsule Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Celecoxib Capsule Market Size by Region (2019-2024)
9.4.3 Asia Celecoxib Capsule Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Celecoxib Capsule Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Type
10.2.1 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Celecoxib Capsule Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Application
10.3.1 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Celecoxib Capsule Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country
10.4.1 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Celecoxib Capsule Introduction
11.1.4 Pfizer Revenue in Celecoxib Capsule Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Celecoxib Capsule Introduction
11.2.4 Teva Revenue in Celecoxib Capsule Business (2019-2024)
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Celecoxib Capsule Introduction
11.3.4 Mylan Revenue in Celecoxib Capsule Business (2019-2024)
11.3.5 Mylan Recent Developments
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Celecoxib Capsule Introduction
11.4.4 Apotex Revenue in Celecoxib Capsule Business (2019-2024)
11.4.5 Apotex Recent Developments
11.5 Lupin
11.5.1 Lupin Company Details
11.5.2 Lupin Business Overview
11.5.3 Lupin Celecoxib Capsule Introduction
11.5.4 Lupin Revenue in Celecoxib Capsule Business (2019-2024)
11.5.5 Lupin Recent Developments
11.6 HENGRUI MEDICINE
11.6.1 HENGRUI MEDICINE Company Details
11.6.2 HENGRUI MEDICINE Business Overview
11.6.3 HENGRUI MEDICINE Celecoxib Capsule Introduction
11.6.4 HENGRUI MEDICINE Revenue in Celecoxib Capsule Business (2019-2024)
11.6.5 HENGRUI MEDICINE Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Celecoxib Capsule Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of 50mg
    Table 3. Key Players of 100mg
    Table 4. Key Players of 200mg
    Table 5. Key Players of 400mg
    Table 6. Global Celecoxib Capsule Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Celecoxib Capsule Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Celecoxib Capsule Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Celecoxib Capsule Market Share by Region (2019-2024)
    Table 10. Global Celecoxib Capsule Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Celecoxib Capsule Market Share by Region (2025-2030)
    Table 12. Celecoxib Capsule Market Trends
    Table 13. Celecoxib Capsule Market Drivers
    Table 14. Celecoxib Capsule Market Challenges
    Table 15. Celecoxib Capsule Market Restraints
    Table 16. Global Celecoxib Capsule Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Celecoxib Capsule Revenue Share by Players (2019-2024)
    Table 18. Global Top Celecoxib Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib Capsule as of 2023)
    Table 19. Global Celecoxib Capsule Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Celecoxib Capsule Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Celecoxib Capsule, Headquarters and Area Served
    Table 22. Global Key Players of Celecoxib Capsule, Product and Application
    Table 23. Global Key Players of Celecoxib Capsule, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Celecoxib Capsule Revenue Market Share by Type (2019-2024)
    Table 27. Global Celecoxib Capsule Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Celecoxib Capsule Revenue Market Share by Type (2025-2030)
    Table 29. Global Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Celecoxib Capsule Revenue Share by Application (2019-2024)
    Table 31. Global Celecoxib Capsule Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Celecoxib Capsule Revenue Share by Application (2025-2030)
    Table 33. North America Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Celecoxib Capsule Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Celecoxib Capsule Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Celecoxib Capsule Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Celecoxib Capsule Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Celecoxib Capsule Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Celecoxib Capsule Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Celecoxib Capsule Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Celecoxib Capsule Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Celecoxib Capsule Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Celecoxib Capsule Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Celecoxib Capsule Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Celecoxib Capsule Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Celecoxib Capsule Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Celecoxib Capsule Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Celecoxib Capsule Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Celecoxib Capsule Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Celecoxib Capsule Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Celecoxib Capsule Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Celecoxib Capsule Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Celecoxib Capsule Product
    Table 68. Pfizer Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 69. Pfizer Recent Developments
    Table 70. Teva Company Details
    Table 71. Teva Business Overview
    Table 72. Teva Celecoxib Capsule Product
    Table 73. Teva Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 74. Teva Recent Developments
    Table 75. Mylan Company Details
    Table 76. Mylan Business Overview
    Table 77. Mylan Celecoxib Capsule Product
    Table 78. Mylan Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 79. Mylan Recent Developments
    Table 80. Apotex Company Details
    Table 81. Apotex Business Overview
    Table 82. Apotex Celecoxib Capsule Product
    Table 83. Apotex Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 84. Apotex Recent Developments
    Table 85. Lupin Company Details
    Table 86. Lupin Business Overview
    Table 87. Lupin Celecoxib Capsule Product
    Table 88. Lupin Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 89. Lupin Recent Developments
    Table 90. HENGRUI MEDICINE Company Details
    Table 91. HENGRUI MEDICINE Business Overview
    Table 92. HENGRUI MEDICINE Celecoxib Capsule Product
    Table 93. HENGRUI MEDICINE Revenue in Celecoxib Capsule Business (2019-2024) & (US$ Million)
    Table 94. HENGRUI MEDICINE Recent Developments
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Celecoxib Capsule Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Celecoxib Capsule Market Share by Type: 2023 VS 2030
    Figure 3. 50mg Features
    Figure 4. 100mg Features
    Figure 5. 200mg Features
    Figure 6. 400mg Features
    Figure 7. Global Celecoxib Capsule Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Celecoxib Capsule Market Share by Application: 2023 VS 2030
    Figure 9. Rheumatoid Arthritis Case Studies
    Figure 10. Osteoarthritis Case Studies
    Figure 11. Acute Pain Case Studies
    Figure 12. Musculoskeletal Pain Case Studies
    Figure 13. Others Case Studies
    Figure 14. Celecoxib Capsule Report Years Considered
    Figure 15. Global Celecoxib Capsule Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Celecoxib Capsule Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Celecoxib Capsule Market Share by Region: 2023 VS 2030
    Figure 18. Global Celecoxib Capsule Market Share by Players in 2023
    Figure 19. Global Top Celecoxib Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib Capsule as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Celecoxib Capsule Revenue in 2023
    Figure 21. North America Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Celecoxib Capsule Market Share by Type (2019-2030)
    Figure 23. North America Celecoxib Capsule Market Share by Application (2019-2030)
    Figure 24. North America Celecoxib Capsule Market Share by Country (2019-2030)
    Figure 25. United States Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Celecoxib Capsule Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Celecoxib Capsule Market Share by Type (2019-2030)
    Figure 29. Europe Celecoxib Capsule Market Share by Application (2019-2030)
    Figure 30. Europe Celecoxib Capsule Market Share by Country (2019-2030)
    Figure 31. Germany Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Celecoxib Capsule Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Celecoxib Capsule Market Share by Type (2019-2030)
    Figure 39. China Celecoxib Capsule Market Share by Application (2019-2030)
    Figure 40. Asia Celecoxib Capsule Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Celecoxib Capsule Market Share by Type (2019-2030)
    Figure 42. Asia Celecoxib Capsule Market Share by Application (2019-2030)
    Figure 43. Asia Celecoxib Capsule Market Share by Region (2019-2030)
    Figure 44. Japan Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Celecoxib Capsule Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Celecoxib Capsule Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Celecoxib Capsule Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Celecoxib Capsule Market Share by Country (2019-2030)
    Figure 54. Brazil Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Celecoxib Capsule Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Pfizer Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 61. Teva Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 62. Mylan Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 63. Apotex Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 64. Lupin Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 65. HENGRUI MEDICINE Revenue Growth Rate in Celecoxib Capsule Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension